Cencora Should See Double-Digit Long-term EPS Growth from Market Growth and Specialty Investments

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora supplies about a third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson; the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.